TEI Biosciences Inc is a leading biomedical company, founded in 1993, that specializes in regenerative medicine for soft tissue repair, reinforcement, and reconstruction. The company, with technology originating from the Massachusetts Institute of Technology, has developed novel biologic products that are favored by surgeons worldwide for challenging repairs in various medical fields including cancer, trauma, diabetic, burn, and sports medicine. TEI's innovations have positively impacted over a quarter of a million patients globally, with its first product, a regeneration matrix for repairing the dura mater, gaining significant recognition in neurosurgical procedures. The company operates within the industries of Biotechnology, Health Care, Life Sciences, and Manufacturing. Although specific details about the last investment and investors are not available, TEI Biosciences continues to be an influential force in the field of biomedicine.
There is no investment information
No recent news or press coverage available for TEI Biosciences Inc.
We care about your data, and we'd love to use cookies make your experience better.
